Overexpression of CDK2 is a prognostic indicator of oral cancer progression

Japanese Journal of Cancer Research

Volumn 92, Issue 3, 2001, Pages 352-360

  Mihara, Mariko ^a   Shintani, Satoru ^a   Nakahara, Yuuji ^a   Kiyota, Akihisa ^a   Ueyama, Yoshiya ^a   Matsumura, Tomohiro ^a   Wong, David T W ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

CDK2; Cyclin A; Cyclin E; Oral cancer; Prognosis

Indexed keywords

ACTIN; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; CYCLINE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE MARKER; DYSPLASIA; FEMALE; GENE OVEREXPRESSION; GROWTH REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MOUTH MUCOSA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TUMOR DIFFERENTIATION;

EID: 0035066779     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb01102.x     Document Type: Article

References (44)

1. G1 events and regulation of cell proliferation
2. Cyclin E/CDK2 and cyclin A/CDK2 kinase associated with p107, and E2F in a temporally distinct manner
3. Human D-type cyclin
4. G1 phase progression: Cyclin on cue
5. Cyclin D and CDK inhibitors come of age
6. Cancer cell cycle
7. Association of human cyclin E with a periodic G1-S phase protein kinase
8. Formation and activation of cyclin E-CDK2 complex during the G1-phase of the human cell cycle
9. Identification of G1 kinase activity for Cdk6, a novel cyclin D partner
10. Cdk6 (PLSTIRE) and Cdk4 (PSK-J3) are distinct subset of the cyclin-dependent kinases that associate with cyclin D1
11. Association of human cyclin E with a periodic G1-S phase protein kinase
12. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition
13. Cyclin A is required at two points in the human cell cycle
14. Acceleration of the G1/S phase transition by expression of cyclin D1 and E with an inducible system
15. Cyclin-dependent regulation of G1 in mammalian fibroblasts
16. Genetic alteration in human gastrointestinal cancers. The application to molecular diagnosis
17. Cyclin as marker of tumor proliferation: Immunocytochemical studies in breast cancer
18. Cyclin E, a potential prognostic marker for breast carcinoma
19. Deregulation of cyclin E in breast cancer
20. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinoma
21. Analysis of cyclin E and CDK2 in ovarian cancer: Gene amplification and RNA overexpression
22. Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix
23. PRAD1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma
24. Alteration of Rb, p16 and cyclin D1 in the tumorigenesis of squamous cell carcinoma
25. Histological typing of oral and oropharyngel tumors
26. Histological classification and grading of malignancy in carcinoma of the larynx
27. The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer
28. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions
29. Design and analysis of randomized clinical trials requiring prolonged observation of each patient
30. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle
31. Mammalian G1 cyclins
32. Phosphorylation of the retinoblastoma protein by cdk2
33. Cdc2-like kinase is associated with the retinoblastoma protein
34. Ordering S phase and M phase in the cell cycle
35. Different expression patterns of cyclin A, D1 and E in human colorectal cancer
36. Thymocyte apoptosis induced by p53-dependent and independent pathways
37. Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness
38. Redundant cyclin overexpression and gene amplification in breast cancer cells
39. Stepwise abnormality of sex steroid hormone receptors, tumor suppression gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma
40. Overexpression of cyclin D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development
41. Heterogeneity of the proliferative fraction and cyclin D1/CDND1 gene amplification in head and neck squamous cell carcinoma
42. Constitutive overexpression of CDK2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells
43. Expression of cell cycle regulatory factors in differentiating osteoblasts: Postproliferative up-regulation of cyclin B and E